Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Editorial

Is Colchicine Involved in Managing Stroke?

Author(s): Antonio Siniscalchi*, Piergiorgio Lochner, Giovambattista De Sarro and Luca Gallelli

Volume 21, Issue 3, 2023

Published on: 26 May, 2023

Page: [145 - 146] Pages: 2

DOI: 10.2174/1570161121666230519143716

Next »
[1]
Siniscalchi A, Iannacchero R, Anticoli S, Pezzella FR, De Sarro G, Gallelli L. Anti-inflammatory strategies in stroke: A potential therapeutic target. Anti-inflammatory strategies in stroke: A potential therapeutic target. Curr Vasc Pharmacol 2016; 14(1): 98-105.
[PMID: 26411421]
[2]
Muir KW, Tyrrell P, Sattar N, Warburton E. Inflammation and ischaemic stroke. Curr Opin Neurol 2007; 20(3): 334-42.
[http://dx.doi.org/10.1097/WCO.0b013e32813ba151] [PMID: 17495630]
[3]
Siniscalchi A, Gallelli L, Malferrari G, et al. Cerebral stroke injury: The role of cytokines and brain inflammation. J Basic Clin Physiol Pharmacol 2014; 25(2): 131-7.
[http://dx.doi.org/10.1515/jbcpp-2013-0121] [PMID: 24515999]
[4]
Alkhalil M, Al-Atta A, Kuzemczak M. Colchicine for the prevention of ischemic stroke: An updated meta-analysis of randomized clinical trials. Brain Circ 2021; 7(3): 187-93.
[http://dx.doi.org/10.4103/bc.bc_24_21] [PMID: 34667902]
[5]
Amarenco P, Lavallée PC, Labreuche J, et al. One-year risk of stroke after transient ischemic attack or minor stroke. N Engl J Med 2016; 374(16): 1533-42.
[http://dx.doi.org/10.1056/NEJMoa1412981] [PMID: 27096581]
[6]
Siniscalchi A, Murphy S, Gray C, De Sarro G, Gallelli L. Biomarkers in unstable carotid plaque: Physiopathology and prediction. Cardiovasc Hematol Agents Med Chem 2022; 20(1): 13-9.
[http://dx.doi.org/10.2174/1871525719666210901131509] [PMID: 34468303]
[7]
Friedrichs K, Klinke A, Baldus S. Inflammatory pathways underlying atrial fibrillation. Trends Mol Med 2011; 17(10): 556-63.
[http://dx.doi.org/10.1016/j.molmed.2011.05.007] [PMID: 21763201]
[8]
da Cunha AA, Ferreira AGK, Loureiro SO, et al. Chronic hyperhomocysteinemia increases inflammatory markers in hippocampus and serum of rats. Neurochem Res 2012; 37(8): 1660-9.
[http://dx.doi.org/10.1007/s11064-012-0769-2] [PMID: 22484967]
[9]
Imazio M, Nidorf M. Colchicine and the heart. Eur Heart J 2021; 42(28): 2745-60.
[http://dx.doi.org/10.1093/eurheartj/ehab221] [PMID: 33961006]
[10]
Imazio M, Brucato A, Ferrazzi P, et al. Colchicine reduces post- operative atrial fibrillation. Circulation 2011; 124(21): 2290-5.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.111.026153] [PMID: 22090167]
[11]
Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021; 42(34): 3227-337.
[http://dx.doi.org/10.1093/eurheartj/ehab484] [PMID: 34458905]
[12]
Nidorf SM, Fiolet ATL, Mosterd A, et al. Colchicine in patients with chronic coronary disease. N Engl J Med 2020; 383(19): 1838-47.
[http://dx.doi.org/10.1056/NEJMoa2021372] [PMID: 32865380]
[13]
Tardif JC, Kouz S, Waters DD, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med 2019; 381(26): 2497-505.
[http://dx.doi.org/10.1056/NEJMoa1912388] [PMID: 31733140]
[14]
Fiolet ATL, Opstal TSJ, Mosterd A, et al. Efficacy and safety of low-dose colchicine in patients with coronary disease: A systematic review and meta-analysis of randomized trials. Eur Heart J 2021; 42(28): 2765-75.
[http://dx.doi.org/10.1093/eurheartj/ehab115] [PMID: 33769515]
[15]
Kelly P, Weimar C, Lemmens R, et al. Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE) – study protocol for a randomised controlled trial. Eur Stroke J 2021; 6(2): 222-8.
[http://dx.doi.org/10.1177/2396987320972566] [PMID: 34414298]
[16]
Ma Z, Chen J, Jin K, Chen X. Colchicine and coronary heart disease risks: A meta-analysis of randomized controlled clinical trials. Front Cardiovasc Med 2022; 9: 947959.
[http://dx.doi.org/10.3389/fcvm.2022.947959] [PMID: 36176989]

© 2024 Bentham Science Publishers | Privacy Policy